Internal Medicine · New York, NY
NPI
1780772947
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
217 Grand St, 3rd Floor Room 301
New York, NY, 10013
Phone (212) 226-9717
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
262 services
Medicare patients, 2024
36
Average age 81
Drug cost, 2024
$4.5M
31,066 prescriptions
Company payments, 2025
$3,086
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yong S Lin was code 99213 (office e&m - established), 118 times for 32 patients. In total Yong S Lin billed 262 services in 17 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 118 | 32 | $71.41 | $8,426 |
| 99214 Office E&M - Established | Office | 36 | 21 | $87.94 | $3,166 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 22 | 22 | $144.27 | $3,174 |
| G0008 Administration of influenza virus vaccine | Office | 20 | 20 | $36.26 | $725 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 20 | 20 | $21.25 | $425 |
By year: 2022 $43K for 606 services; 2023 $29K for 416 services; 2024 $18K for 262 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yong S Lin prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,639 prescriptions and refills. In total Yong S Lin wrote 31,066 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,639 | 4,287 | 419 | $16K |
| Amlodipine Besylate Generic | 2,563 | 4,049 | 376 | $13K |
| Vascepa Icosapent Ethyl | 2,240 | 2,789 | 306 | $975K |
| Losartan Potassium Generic | 2,208 | 3,631 | 346 | $13K |
| Diclofenac Epolamine Generic | 1,971 | 2,118 | 247 | $1.1M |
| Metformin Hcl Generic | 1,342 | 2,173 | 202 | $6,860 |
| Raloxifene Hcl Generic | 1,051 | 1,527 | 146 | $17K |
| Tamsulosin Hcl Generic | 1,034 | 1,523 | 156 | $7,380 |
| Fluticasone Propionate Generic | 707 | 726 | 206 | $7,572 |
| Metoprolol Succinate Generic | 595 | 893 | 88 | $3,738 |
| Montelukast Sodium Generic | 593 | 721 | 138 | $3,001 |
| Omeprazole Generic | 541 | 574 | 185 | $4,080 |
| Januvia Sitagliptin Phosphate | 526 | 770 | 77 | $429K |
| Ammonium Lactate Generic | 496 | 514 | 152 | $15K |
| Esomeprazole Magnesium Generic | 489 | 543 | 114 | $6,785 |
Brand drugs: 7,070 claims; generic drugs: 23,555 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yong S Lin $3,086 ($3,086 in general payments such as food, travel and fees) from 9 companies. The largest payer was Gilead Sciences, Inc. with $1,038.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 21 | $1,038 |
| Amgen Inc. AMGN | 9 | $862 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $549 |
| Novo Nordisk Inc NVO | 4 | $192 |
| Madrigal Pharmaceuticals MDGL | 1 | $137 |
| Axsome Therapeutics, Inc. AXSM | 1 | $103 |
| Lundbeck LLC | 4 | $96.97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $83.37 |
| Mallinckrodt Hospital Products Inc. | 1 | $23.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.